Improved outcomes associated with hematopoietic stem cell transplantation for patients with juvenile myelomonocytic leukemia

Blood. 2015 Jul 23;126(4):561-2. doi: 10.1182/blood-2015-05-644161.

Authors

Quan Zhao¹, Kris Michael Mahadeo², Neena Kapoor³, Hisham Abdel-Azim³

Affiliations

¹ Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA.
² Pediatric Blood and Marrow Transplantation Program, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY.
³ Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA.

PMID: 26206948
DOI: 10.1182/blood-2015-05-644161

No abstract available

Publication types

Letter

MeSH terms

Child, Preschool
Female
Follow-Up Studies
Graft vs Host Disease / drug therapy
Hematopoietic Stem Cell Transplantation*
Humans
Immunosuppressive Agents / therapeutic use
Infant
Leukemia, Myelomonocytic, Juvenile / therapy*
Male
Neoplasm Staging
Remission Induction
Retrospective Studies
Transplantation, Homologous

Substances

Immunosuppressive Agents